We previously proposed that POT1 prevents ATR signaling at telomeres by excluding RPA from the single-stranded TTAGGG repeats. Here, we use a Shld1-stabilized degron-POT1a fusion (DD-POT1a) to study the telomeric ATR kinase response. In the absence of Shld1, DD-POT1a degradation resulted in rapid and reversible activation of the ATR pathway in G1 and S/G2. ATR signaling was abrogated by shRNAs to ATR and TopBP1, but shRNAs to the ATM kinase or DNA-PKcs did not affect the telomere damage response. Importantly, ATR signaling in G1 and S/G2 was reduced by shRNAs to RPA. In S/G2, RPA was readily detectable at dysfunctional telomeres, and both POT1a and POT1b were required to exclude RPA and prevent ATR activation. In G1, the accumulation of RPA at dysfunctional telomeres was strikingly less, and POT1a was sufficient to repress ATR signaling. These results support an RPA exclusion model for the repression of ATR signaling at telomeres.
INTRODUCTION
Mammalian telomeres evade DNA damage checkpoints through the agency of shelterin, a six-subunit protein complex that binds to telomeres (reviewed in Palm and de Lange, 2008; de Lange, 2009) . One of several pathways repressed by shelterin is the ATR kinase signaling cascade, which responds to singlestranded DNA (ssDNA). ATR signaling is activated by recessed 5 0 ends, which occur at stalled replication forks and at DNA double-stranded breaks (DSBs) that have been processed (reviewed in Cimprich and Cortez, 2008) . Telomeres are at risk of inappropriately activating the ATR kinase because they have a substantial segment of single-stranded TTAGGG repeats, either at their 3 0 end or in the form of the displacement loop (D loop) at the base of the t loop (McElligott and Wellinger, 1997; Makarov et al., 1997; Chai et al., 2006; Griffith et al., 1999) . The single-stranded region is estimated to be 50-400 nt in length, which is sufficient for the activation of the ATR kinase pathway in vitro (MacDougall et al., 2007) .
The activation of ATR signaling requires RPA, an abundant heterotrimeric single-stranded DNA binding protein that functions in DNA replication, homology-directed DSB repair, and DNA damage signaling. The RPA-coated single-stranded DNA interacts with the ATRIP component of the ATR kinase complex, thereby recruiting the ATR kinase to DNA lesions (Zou and Elledge, 2003) . Activation of the RPA-bound ATR kinase requires TopBP1, a multiple BRCT domain protein that interacts with Rad9 in the complex that is formed on the 5 0 end flanking the single-stranded DNA by the Rad17 clamploader and the Rad9-Hus1-Rad1 clamp (Furuya et al., 2004; Kumagai et al., 2006; Delacroix et al., 2007; Lee et al., 2007; Mordes et al., 2008) . The dual interaction of TopBP1 with Rad17/9-1-1 and ATR/ ATRIP allows the ATR activating domain (AAD) of TopBP1 to activate the kinase (Kumagai et al., 2006; Mordes et al., 2008) . The ATR kinase phosphorylates S/TQ sites on a large number of target proteins (Matsuoka et al., 2007) , including factors that mediate cell-cycle arrest, DNA repair, replisome stability, and replication restart. Constitutive activation of these pathways at the natural ends of mammalian chromosomes would not be compatible with cell viability and proliferation.
The repression of ATR signaling at vertebrate telomeres requires POT1, the component of shelterin that specifically binds single-stranded TTAGGG repeats (Hockemeyer et al., 2006; Churikov and Price, 2008; Denchi and de Lange, 2007; Guo et al., 2007) . POT1 is bound to telomeres through its interaction with TPP1, which in turn associates with the double-stranded telomeric DNA binding proteins (TRF1 and TRF2) via TIN2 (reviewed in Palm and de Lange, 2008) . Although POT1 proteins rely on TPP1, TRF1, TRF2, and TIN2 for their accumulation at telomeres, the converse is not true. Deletion of POT1 proteins from mouse cells does not perturb the other shelterin subunits, allowing assignment of specific functions to POT1 based on gene deletion experiments in mouse cells (Hockemeyer et al., 2006) .
Unlike most vertebrates, including humans, mice and other rodents have two POT1 genes, coding for distinct telomeric proteins, POT1a and POT1b (Hockemeyer et al., 2006) . POT1a and POT1b are similar in abundance, have the same affinity for telomeric DNA, and both require TPP1 for their recruitment to telomeres. Despite these similarities, POT1a and POT1b have largely nonoverlapping functions that are specified by the N-terminal OB fold DNA binding domains (Hockemeyer et al., 2006; Palm et al., 2009; Hockemeyer et al., 2008) . POT1a is required for the repression of the ATR kinase, whereas the primary function of POT1b is to protect telomeres from excessive shortening of the 5 0 ended C-rich telomeric strand and accompanying extension of the 3 0 overhangs. Deletion of POT1a induces phosphorylation of Chk1 and the formation of telomere dysfunction induced foci (TIFs) at telomeres in a subset of the cells (Hockemeyer et al., 2006; Denchi and de Lange, 2007) . Cells lacking POT1b do not show these indices of telomere deprotection but have a 2-to 4-fold increase in the amount of single-stranded TTAGGG repeats at telomeres (Hockemeyer et al., 2006; Hockemeyer et al., 2008) . However, deletion of both POT1a and POT1b exacerbates the DNA damage response, extending the TIF response to most cells (Hockemeyer et al., 2006) . Such POT1a/b DKO cells also show an increased rate of telomere fusions in G2, undergo telomere recombination when Ku70/80 is absent, and show a high rate of endoreduplication (Palm et al., 2009; Hockemeyer et al., 2006; Wu et al., 2006) . To study the repression of ATR signaling at telomeres, we have developed a switchable allele of POT1a that allows rapid and reversible deprotection of chromosome ends. Previous inducible inactivation of shelterin components relied on doxycyclin-inducible expression, Cre-mediated gene deletion, short hairpin RNA (shRNA)-mediated knockdown, and a temperature-sensitive mutant. The Shld1 system has the advantage that the effect is rapid and reversible and can be applied to most proteins by constructing a simple fusion protein (Banaszynski et al., 2006) .
RESULTS AND DISCUSSION
Reversible Telomere Deprotection with a Shld1-Controlled POT1a A switchable POT1a allele was generated by fusion to the destabilizing domain (DD) of the inherently unstable FKBP12-L106P mutant (Banaszynski et al., 2006) (Figure 1A ). The unfolding and concomitant degradation of this FKBP12 degron can be blocked by addition of the stabilizer Shield-1 (Shld1) to cell culture media (Banaszynski et al., 2006) . The DD-POT1a fusion was expressed in POT1a/b DKO cells from which the endogenous POT1 proteins were subsequently deleted with Cre recombinase. A clonal derivative lacking the endogenous POT1a/ b (c223) was used for the studies below ( Figure S1A available online). The DD-POT1a fusion protein was expressed at a slightly higher level than the endogenous POT1a (see Figure 6 below). As anticipated, DD-POT1a levels gradually decreased over 6-8 hr to $10% of the original expression level when Shld1 was absent ( Figures 1A and 1B) . At later time points, DDPOT1a reached a new, lower, steady-state level reflecting its faster degradation in the absence of Shld1 ( Figure 1B) . When stabilized by Shld1, DD-POT1a was functional as evidenced by several indices of telomere protection and cells proliferated at a normal rate ( Figures 1B-1F and data not shown). Telomeres became rapidly deprotected upon withdrawal of Shld1, resulting in the formation of TIFs and phosphorylation of H2AX and MCM2 within 6 hr ( Figures 1B-1D and Figure S1B ). The extent of telomere dysfunction reached a maximal level at 4-8 hr after removal of Shld1 and persisted for at least 6 days ( Figure 1D and Figure S1B ). At later time points, the cells showed phosphorylation of Chk1 and Chk2 and stopped proliferating (Figures 1E and 1F) . Upon readdition of Shld1, DD-POT1a was re-expressed and reached maximal levels after 2 hr ( Figure 1G ). This rise in POT1a was accompanied by the restoration of telomere function in most cells, although full telomere protection was not achieved until $12 hr after addition of Shld1 ( Figure 1H ).
Specific Activation of the ATR Pathway
Previous studies showed that ATR signaling is activated within 3-4 days after deletion of POT1a or POT1a and -b. Inhibition of the ATR kinase with an shRNA in this context diminished the response but did not fully abrogate it, indicating either incomplete ATR inhibition or signaling through another pathway (Denchi and de Lange, 2007) . To determine whether ATR is in fact the only transducer of telomere damage response in this setting, we infected DD-POT1a cells with shRNAs against ATM, ATR, or DNA-PKcs individually or in combination (Figure 2A) and measured the damage response by TIF analysis at 6 hr after Shld1 withdrawal (Figures 2B and 2C) . Whereas ATM and DNA-PKcs knockdown did not diminish the TIF response, knockdown of ATR severely decreased this outcome of telomere deprotection. The effect of ATR shRNA was not further exacerbated by simultaneous knockdown of ATM or DNA-PKcs, indicating that neither of these kinases played a substantial role in the response to the telomere damage generated by POT1a loss. The involvement of ATR in this telomere damage response was confirmed by inhibition of TopBP1 with several shRNAs, which resulted in a dramatic reduction in the TIF response to a level barely above background ( Figures 2C and 2D and data not shown). Thus, it is likely that the ATR kinase is the only transducer of the telomeric DNA damage signal after POT1 deletion. This result is consistent with the view that loss of POT1a and -b exposes the single-stranded telomeric DNA while other aspects of telomere protection, including repression of ATM signaling, remain intact.
Activation of ATR Signaling in G1 and S/G2
The rapid degradation of DD-POT1a allowed dissection of the cell-cycle aspects of ATR kinase signaling. Using mitotic shake-off, we harvested M phase cells and allowed them to progress through the cell cycle for 4 hr, resulting in a population of cells in G1 as evidenced by their DNA content and minimal incorporation of BrdU ( Figure 3A) . A mixture of S and G2 cells was obtained 4 hr after release from a double thymidine block ( Figure 3A) . Upon Shld1 withdrawal, the TIF response was not significantly different in G1 versus S/G2 and indistinguishable from the TIF response in asynchronous cells (p > 0.05; Figures  3B and 3C ).
The activation of ATR signaling in G1 was further confirmed in an asynchronous population of cells that was labeled with BrdU for 4 hr in the absence of Shld1. Because of the duration of the labeling period, both S phase cells and cells that were in G2 at the time of harvest are expected to be BrdU positive. Withdrawal of Shld1 did not affect the fraction of cells that incorporated BrdU ($35%) ( Figure 3D ). Importantly, DNA damage foci occurred in close to 90% of the cells, regardless of whether they were BrdU positive (S/G2) or BrdU negative (G1) ( Figure 3D ). Thus, POT1a inactivation in absence of POT1b resulted in the induction of ATR signaling in G1 cells as well as in S/G2.
RPA Required for ATR Activation in G1 and in S/G2 ShRNA-mediated knockdown was employed to query the role of RPA in the activation of the ATR pathway. Lowering of the expression levels of RPA32 or RPA70 significantly diminished the formation of TIFs at telomeres lacking POT1a and POT1b ( Figures 4A-4C ). The ATR signaling was not fully abrogated by the RPA shRNAs, presumably because of the essential nature of RPA which precludes more complete knockdown.
We next asked whether RPA was required for ATR signaling in both G1 and S/G2 cells. To address this question, we again used a 4 hr BrdU pulse to identify cells that had not replicated their DNA in the 4 hr prior to analysis and therefore were most likely in G1 at the time of harvesting. If RPA was required for ATR activation in S/G2 but not in G1, we would expect to observe a difference in the effect of RPA shRNA on the occurrence of 53BP1 foci in BrdU-positive and -negative cells. The overall incorporation rate of BrdU was not affected by the RPA shRNA. The telomeric DNA damage response was reduced to a similar extent in BrdU-positive and -negative cells, implying that RPA70 is required to activate ATR both during and outside S phase ( Figure 4D ). A similar result was obtained with the shRNA to RPA32 (data not shown). These results demonstrate that RPA directly contributes to ATR activation at dysfunctional telomeres generated by POT1a/b loss both in G1 and in S/G2. 
Different Levels of RPA Accumulation at Telomeres in G1 and S/G2
A previous report noted RPA colocalizing with telomeres upon inhibition of human POT1, but the data were difficult to interpret as a result of the high level of pannuclear RPA signals remaining after the fixation conditions used (Barrientos et al., 2008) . We therefore examined the localization of RPA at telomeres by using the DD-POT1a system and a well-established protocol for detection of RPA foci that involves pre-extraction of nucleoplasmic proteins (Dimitrova et al., 1999; Mirzoeva and Petrini, 2001) . When DD-POT1a was stabilized with Shld1, RPA foci were absent from most cells ( Figure 5A ). As expected, $30% of the cells exhibited the numerous small RPA32 foci indicative of ongoing DNA replication, but these foci did not colocalize with telomeric DNA (data not shown) and did not contain 53BP1 ( Figure 5B ). When DD-POT1a was removed, RPA32 formed readily detectable foci that colocalized with 53BP1 and telomeric DNA ( Figure 5A ). After Shld1 removal, $35% of the cells in the asynchronous population had more than 15 RPA foci that colocalized with 53BP1 and therefore were presumed to represent the accumulation of RPA at dysfunctional telomeres ( Figure 5C ). In the S/G2 cell population, 70%-80% of the cells showed RPA foci coinciding with 53BP1 ( Figures 5B and 5C ), indicating that most of the S/G2 cells with 53BP1 at their telomeres ($90%, see Figure 3C ) also showed telomeric accumulation of RPA. A different result was obtained with G1 cells. Although 90% of G1 cells had 53BP1 at their telomeres after Shld1 removal ( Figure 3C ), the RPA foci in G1 were weak and only about 40% cells showed more than five RPA foci colocalizing with 53BP1 ( Figures 5D and 5E ). The intensity of RPA staining at the telomeres of the remainder of the TIF-positive G1 cells appeared to be too low to be detected under these conditions. Together, these experiments establish that RPA localizes to most telomeres that have lost protection by POT1a/b, regardless of the cell-cycle stage.
Interestingly, RPA is more readily detectable at deprotected telomeres in S/G2, presumably indicating that the amount of RPA per telomere is greater. Why RPA loading on the dysfunctional telomeres is increased in S/G2 is not clear. The $2-fold increase in the single-stranded DNA at telomeres in S phase ( Figure S4 ) seems insufficient to explain the much more intense RPA staining. It is not known whether the ability of RPA to load onto ssDNA is increased in S phase. Trimeric RPA is expressed equally throughout the cell cycle (Loo and Melendy, 2000) , and while RPA32 is phosphorylated in S phase and in response to DNA damage, the effect of this modification on its ability to associate with ssDNA is not known (reviewed in Binz et al., 2004) . 
Different Requirements for POT1-Mediated Protection in G1 and S/G2
Given the prominent difference in RPA staining at dysfunctional telomeres in G1 and S/G2, we determined the effect of cell-cycle stage on the ability of POT1a and -b to protect telomeres. Previous data showed that the two POT1 proteins differ in their ability to repress the DNA damage response at the telomeres. Whereas deletion of both genes leads to telomere deprotection in all cells, only 30%-40% of POT1a-deficient cells show TIFs. To determine whether these cells represent a specific cell-cycle stage, we expressed Myc-tagged POT1b in the c223 DD-POT1a clone lacking both of the endogenous POT1 proteins ( Figure 6A ). Immunoblotting showed that DD-POT1a and myc-POT1b are expressed at a level slightly higher than the endogenous proteins ( Figure 6A ). As expected, the expression of myc-POT1b rapidly reduced the excessive overhang signal associated with the absence of POT1b (Figure 6B ) and limited the TIF response to $40% of the cells (Figures 6C and 6D) .
To determine whether the residual TIF response was limited to a specific cell-cycle phase, we examined cells after a 4 hr BrdU pulse to differentiate G1 cells from those in S and G2. The expression of POT1b did not affect the BrdU uptake of cells ( Figures 6E and 6F ). When POT1b was absent, nearly 90% of the cells contained 53BP1 foci, regardless of whether they were in G1 or S/G2. However, when POT1b was present, the 53BP1 foci occurred primarily in cells containing BrdU, indicating that the TIF response was limited to S/G2 cells ( Figures  6E and 6F) . Thus, when POT1b is present, POT1a is required to repress ATR signaling in S/G2 but not in G1.
Different Requirements for Restoration of Telomere Protection in G1 versus S/G2
We next tested the effect of cell-cycle stage on the restoration of telomere protection in cells re-expressing POT1a with or without POT1b ( Figures 1G, 1H , 7A, and 7B). Using cells synchronized in G1 and S/G2, we monitored the dissipation of the telomere damage response over 4 hr after addition of Shld1. The expression of myc-POT1b did not affect the cell-cycle profile of the cells ( Figure S5 ). The re-establishment of telomere protection by POT1a alone was nearly complete in G1 cells but substantially delayed in S/G2 cells ( Figure 7C and Figure S3 ). After 4 hr, more than 50% of the S/G2 population remained TIF positive, and full restoration of telomere protection required a time period that would include progression through mitosis. In contrast, when POT1b was also present, telomere protection was reestablished efficiently in S/G2 cells ( Figure 7C ). Restoration of the telomeres appeared nearly complete in 4 hr ( Figure 7C) , even though the kinetics of POT1a re-expression in the S/G2 cells was not altered ( Figure 7D ). Thus, POT1a alone is sufficient to rapidly re-establish telomere protection in G1. In contrast, (D) IF for RPA32 (red) and 53BP1 (green) in G1 cells after Shld1 withdrawal. Cells were collected as described in Figure 3 . Three independent images of G1 cells after Shld1 withdrawal are shown. An enlarged nucleus is shown on the right together with three 53BP1 foci that also contain RPA. The enlarged images in (B) and (D) were processed identically so that the relative intensities of 53BP1 and RPA in the foci can be compared. (E) Quantification the fraction of G1 cells with 53BP1 foci that contain RPA as detected as in (D). Cells with five or more foci were scored positive. The bar graphs represent the average from three independent experiment and the SDs. See also Figure S4. rapid restoration of telomere function in S/G2 requires re-expression of POT1a in a POT1b proficient setting. It is likely that the presence of POT1b facilitates the restoration of telomere protection in S/G2 by both limiting the extent of the ssDNA at telomere ends and by binding to the TTAGGG repeats.
In absence of POT1b, the restoration of telomere protection by POT1a is much faster in G1 than in S/G2 ( Figure 7C ). This difference may be due to a temporary increase in the single-stranded overhangs in S phase (see Figure S2) , titration of POT1a to ssDNA at the replication fork, or a change in POT1a (e.g., modification) altering its ability to bind to telomeres. A fourth possibility, which we favor, is that the slower restoration of telomeres in S/G2 is related to the apparently greater amount of RPA loaded on telomeres (Figure 5) , which would require higher levels of POT1a in order to effectively remove RPA from the ssDNA.
Conclusions
A priori, there are a number of ways in which POT1 proteins might block ATR signaling. As a protein positioned close to (or at) the 5 0 recessed end of the telomere, POT1 could prevent the loading of the 9-1-1 clamp or interfere with the interaction between 9-1-1 and TopBP1. POT1 could also act further downstream in the signaling cascade, as has been proposed for its protection of telomeres in fission yeast (Carneiro et al., 2010) . The current data support a simpler model, previously proposed by us and others (Denchi and de Lange, 2007; Barrientos et al., 2008; Guo et al., 2007; Churikov and Price, 2008) , in which POT1 prevents activation of the ATR pathway by blocking the binding of RPA to the single-stranded TTAGGG repeats. In agreement with this RPA exclusion model, RPA appears at telomeres and is required for activation of the ATR kinase once POT1a/b are removed. Furthermore, consistent with POT1a competing with RPA, telomere protection by POT1a can be re-established in a few hours and does not require progression through S phase or mitosis. Finally, RPA is more prominent at dysfunctional telomeres in S/G2 versus G1, and this difference correlates with the increased requirement for POT1 proteins at telomeres in S/G2. The future challenge will be to establish the mechanism by which POT1 proteins, which are not abundant (Takai et al., 2010) , exclude the abundant RPA from the telomeric DNA.
EXPERIMENTAL PROCEDURES
Plasmid Constructs DD-POT1a was expressed from pBabe-DD-ER-POT1a encoding full-length human FKBP12, estrogen-receptor (ER) ligand-binding domain, and fulllength mouse POT1a was generated by PCR and ligated into a pBabe-puro retroviral vector. The F36V and L106P mutations were introduced into FKBP12 with the QuickChange Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's instructions. Although the fusion construct contained the ER domain, this feature was not employed in the experiments since preliminary data indicated poor regulation of POT1a with tamoxifen. pLPC-N-myc-POT1b encoding full-length mouse POT1b preceded by a myc tag was generated from the pLPC-N-myc retroviral vector. The endogenous POT1a and -b genes were deleted with Hit&Run Cre recombinase, and clones were then isolated with cloning cylinders in the presence of 1 mM Shld1 (BD Biosciences). One clone, c223, was selected for further study based on the absence of the endogenous POT1a/b and its rapid response after Shld1 withdrawal. For expression of POT1b in this clone, pLPC-N-mycPOT1b was introduced by four retroviral infections at 12 hr intervals with supernatant from transfected ecotropic Phoenix cells. So that the absence of the endogenous POT1a and POT1b could be confirmed, genotyping PCRs were preformed with standard DNA isolation techniques and Takara Taq polymerase (Madison, WI, USA). The sequencing PCR primers for endogenous POT1a and 1b are as follows:
Generation of DD-POT1a-Expressing Cells
POT1a FLOX PCR: 6-FRTfw-2, TGAGCCCAGAAAGCGAAGGAG; 6-FRTbw1, ACAAACCCACCCCGTCAGAGTAAG POT1a Dex3 PCR: 6-allfw-2, CTTCCCTGTTTGCCCTCCTTTACT; 6-allbw-2, TTCCCCCTTTCATTTTCTTTTCTC POT1b FLOX PCR: 17wtfw-1, CGCTGGGGAGGGTATCGTAG; 6-FRTfw-2, TGAGCCCAGAAAGCGAAGGAG POT1b Dex3 PCR: 17-allfw-1, GTTGCCCCTATCATCCTACACG; 17-FRTbw-2, TGTGTTGGGAGAGGAAGTGAAAGA PCRs were performed for 32 cycles (94 C for 45 s, 60 C for 45 s, 72 C for 60 s).
shRNAs Previously published shRNAs against ATRsh3-1 (GGAGATGCAACTCGT TTAA) (Denchi and de Lange, 2007) , ATMsh3 (GGAAGTCAAGGAACA ACAACTA), and DNA-PKcssh3 (CGGATCCCTGGTAGAACAGT) were introduced by four infections at 12 hr intervals with pSuperior-hygro (ATM sh3 and ATR sh3-1) or pSuper-puro (DNA-PKcs sh3) retroviral vectors. For combined knockdown of ATR and ATM, or ATR and DNA-PKcs, shRNAs against ATM or DNA-PKcs were introduced first by four infections at 12 hr intervals with supernatant from transfected ecotropic Phoenix cells, and (A) Immunoblot for DD-POT1a and myc-POT1b expression after Shld1 addition. Cells were generated as in Figure 6 and deprived of Shld1 for 16 hr. Shld1 was added back for the indicated times, and the cells were processed for immunoblotting (POT1a, Ab1221; POT1b, Ab1223).
(B) Quantification of the TIF response after Shld1 addition in POT1b-proficient cells. Cells were collected as described in (A) and processed for IF-FISH to score TIFs as in Figure 1 . (C) Quantification of the TIF response after Shld1 addition in synchronized cells deficient or proficient for POT1b as indicated. G1 cells were collected after mitotic shake-off and plated in the absence of Shld1 for 4 hr, after which Shld1 was added back for the indicated times before analysis of the TIF response. S/G2 cells were obtained with a double thymidine block. After the release from the second thymidine block, cells were incubated in the absence of Shld1 for 4 hr. Shld1 was then added back for the indicated times before processing for TIF analysis.
(D) Time course of DD-POT1a and myc-POT1b levels of the S/G2 cells described in (C). See also Figure S5 . 
IF and IF-FISH
One million cells were grown on 12 mm coverslips and fixed for 10 min in 2% paraformaldehyde at room temperature. Cells were rinsed with PBS, permeabilized with 0.5% NP-40 in PBS for 10 min, blocked with PBG (1% BSA, 0.2% cold fish gelatin in PBS) for 30 min, and incubated with antibody against 53BP1 (rabbit polyclonal; 100-304A, Novus Biologicals) diluted in PBG for 1 hr at room temperature. After PBS washes, cells were incubated with Alexa Fluor 555 goat anti-rabbit secondary antibody (Invitrogen) for 1 hr. For IF-FISH, cells were fixed again with 2% paraformaldehyde for 8 min, dehydrated consecutively in 70%, 95%, and 100% ethanol for 5 min each, and allowed to dry completely. Hybridizing solution (70% formamide, 1 mg ml À1 blocking reagent (Roche), 10 mM Tris-HCl (pH 7.2), containing PNA probe FITC-OO-(AATCCC) 3 (Applied Biosystems) was added to each coverslip and the cells were denatured by heating for 10 min at 80 C on a heat block. After 2 hr incubation at room temperature in the dark, cells were washed twice with washing solution (70% formamide, 10 mM Tris-HCl [pH 7.2]) and twice in PBS. For BrdU costaining, cells were fixed again with 2% paraformaldehyde for 8 min, followed by incubation of denaturing solution 4 N HCl for 10 min. After extensive wash in PBS, cells were incubated with FITC-conjugated anti-BrdU (BD Biosciences) for 1 hr. For RPA and 53BP1 costaining, the in situ cell fractionation protocol was used as described (Mirzoeva and Petrini, 2001) . RPA32 was detected with a mouse monoclonal antibody (Abcam). DNA was counterstained with DAPI and slides were mounted in anti-fade reagent (ProLong Gold, Invitrogen). Digital images were captured with a Zeiss Axioplan II microscope with a Hamamatsu C4742-95 camera using Improvision OpenLab software.
Cell Synchronization and FACS Analysis
For mitotic shake-off, 2 to 3 3 10 6 cells were plated in T150 flasks and incubated for 16-24 hr. Mitotic cells were harvested by manual tapping of the flasks, and the supernatant was transferred to a 250 ml centrifuge bottles and kept on ice. The selecting process was repeated twice to collect sufficient numbers of mitotic cells over a 1 hr period. Cells were then centrifuged at 1000 rpm for 5 min and replated for experiments and FACS analysis. For double-thymidine block, 5 3 10 5 cells were plated on 10 cm dishes and grown for 16-24 hr. Thymidine was added to a final concentration of 2 mM, and cells were incubated for 14-16 hr. Cells were washed three times with PBS and grown in fresh medium for 10-12 hr. A second thymidine block was performed the same way and cells were incubated for another 14-16 hr. Finally, cells were washed three times with PBS and released into fresh medium. For FACS analysis, 1 3 10 6 cells were collected, washed in PBS, and fixed in ice-cold 70% ethanol for at least 24 hr. Cells were recovered by centrifugation and resuspended in 0.5 ml of 0.5% BSA in PBS containing 5 mg propidiumiodide and 100 mg RNase A per ml. The samples were analyzed on a FACScalibur flow cytometer (Becton Dickinson). Data analysis was performed with FlowJo software.
Analysis of Telomeric DNA Mouse telomeric DNA was analyzed on CHEF gels as described previously (Celli and de Lange, 2005) . Cells were resuspended in PBS and mixed 1:1 (v/v) with 2% agarose (SeaKem agarose) to obtain 5 3 10 5 cells per agarose plug. Plugs were digested overnight with 1 mg ml -1 Proteinase K (in buffer containing 100 mM EDTA, 0.2% sodium deoxycolate, 1% sodium lauryl sarcosine), washed extensively with TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM EDTA), equilibrated with MboI digestion buffer for 1 hr, and incubated overnight at 37 C with 60 U MboI in 0.5 ml per plug. The following day, the plugs were washed once in TE and once in water and were equilibrated in 0.5 3 TBE. Plugs were loaded on a 1% agarose/0.5 3 TBE gel and run for 24 hr with the CHEF-DRII PFGE apparatus (BioRad) in 0.5 3 TBE running buffer. The settings were as follows: initial pulse, 5 min; final pulse, 5 min; 6 V cm À1 ; 14 C. In-gel hybridization of the native gel with a 32 P-ATP end-labeled (CCCTAA) 4 oligonucleotide and subsequent denaturation and hybridization steps were performed as described. Gels were exposed onto a PhosphoImager screen overnight, and the single-stranded G overhang signal was quantified with ImageQuant software and normalized to the total telomeric DNA quantified after denaturation. (A) G1 c223 cells were collected after mitotic shake-off and plated in the presence or absence of Shld1 for 4 hrs. S/G2 cells were obtained with a double thymidine block and release. After the release from the 2 nd thymidine block, cells were incubated in the presence or absence of Shld1 for 4 hrs. Cells were processed for in-gel assay to detect 3' overhang first, then denatured in situ and rehybridized to the same probe to detect the total TTAGGG signal. Overhang signals were quantified with ImageQuant software and normalized to the total TTAGGG signal in the same lane. Relative values are given with lane 1 set to 1. Cells deficient (A) or proficient for POT1b (B) were synchronized using a double thymidine block. After the release from the 2 nd thymidine block, cells were incubated in the absence of Shld1 for 4 hrs. Shld1 was then added back for the indicated times before processing for FACS analysis to determine whether the presence of myc-POT1b affects the cell cycle profile.
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